Trial Profile
Safety and Effect of Liraglutide in Patients With Type 2 Diabetes and Severe Renal Insufficiency.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 19 Sep 2014 Results presented at the 50th Annual Meeting of the European Association for the Study of Diabetes.
- 01 Oct 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 30 Sep 2011 Actual initiation date (Sep 2011) added as reported by ClinicalTrials.gov.